• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comment on: Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial.

作者信息

Lacout Alexis, Azalbert Xavier, Reverbel Corinne, Lesgards Jean-François, Cerdan Dominique, Lounnas Valère, Guillaume Gérard, Zizi Martin, Perronne Christian

机构信息

Radiodiagnostic, Surgical Medical Center of Tronquieres-Elsan, Aurillac, France.

Toulouse School of Economics Alumni, Garches, France.

出版信息

J Antimicrob Chemother. 2025 Mar 3;80(3):891-892. doi: 10.1093/jac/dkae385.

DOI:10.1093/jac/dkae385
PMID:39499209
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11879202/
Abstract
摘要

相似文献

1
Comment on: Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial.评论：恩适得对感染奥密克戎变异株之前或奥密克戎变异株的新冠肺炎住院患者的抗病毒作用：随机发现试验的建模分析
J Antimicrob Chemother. 2025 Mar 3;80(3):891-892. doi: 10.1093/jac/dkae385.
2
Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial.Evusheld 对感染前奥密克戎或奥密克戎变异株的 COVID-19 住院患者的抗病毒效果：一项随机 DisCoVeRy 试验的建模分析。
J Antimicrob Chemother. 2024 Nov 4;79(11):2887-2895. doi: 10.1093/jac/dkae301.
3
Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-omicron or omicron variants: a modelling analysis of the randomized DisCoVeRy trial-authors' response.恩适得对感染前奥密克戎或奥密克戎变异株的COVID-19住院患者的抗病毒作用：随机发现试验的建模分析——作者回应
J Antimicrob Chemother. 2025 Mar 3;80(3):892-893. doi: 10.1093/jac/dkae447.
4
Clinical efficacy of anti-SARS-CoV-2 monoclonal antibodies in preventing hospitalisation and mortality among patients infected with Omicron variants: A systematic review and meta-analysis.抗SARS-CoV-2单克隆抗体预防感染奥密克戎变异株患者住院和死亡的临床疗效：一项系统评价和荟萃分析
Rev Med Virol. 2023 Jul;33(4):e2439. doi: 10.1002/rmv.2439. Epub 2023 Mar 16.
5
Comparative Effectiveness of Antivirals and Monoclonal Antibodies for Treating COVID-19 Patients Infected With Omicron Variant: A Systematic Review and Network Meta-Analysis.抗病毒药物和单克隆抗体治疗感染奥密克戎变异株的COVID-19患者的比较疗效：一项系统评价和网状Meta分析
Influenza Other Respir Viruses. 2024 Dec;18(12):e70065. doi: 10.1111/irv.70065.
6
Bacterial and Viral Coinfections in Adult Patients Hospitalized With COVID-19 Throughout the Pandemic: A Multinational Cohort Study in the EuCARE Project.整个大流行期间因COVID-19住院的成年患者中的细菌和病毒合并感染：EuCARE项目中的一项多国队列研究
J Infect Dis. 2025 Jul 11;231(6):e1091-e1101. doi: 10.1093/infdis/jiaf167.
7
Effects of booster vaccination on post-treatment oxygen deterioration in hospitalized mild-to-moderate COVID-19 Japanese patients with comorbidities during the Omicron wave.奥密克戎毒株流行期间，加强疫苗接种对合并症的日本轻至中度新冠肺炎住院患者治疗后氧恶化的影响。
J Infect Chemother. 2025 Aug;31(8):102764. doi: 10.1016/j.jiac.2025.102764. Epub 2025 Jun 26.
8
Household clusters of SARS-CoV-2 Omicron subvariants contemporaneously sequenced from dogs and their owners.从狗及其主人身上同时测序的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）奥密克戎亚变体的家庭聚集情况。
mSphere. 2025 Jul 2:e0007425. doi: 10.1128/msphere.00074-25.
9
The Clinical Impact of the Omicron Variant on Octogenarian Hospitalized COVID-19 Patients: The Results from CoviCamp Cohort.奥密克戎变异株对80岁及以上住院COVID-19患者的临床影响：CoviCamp队列研究结果
Biomedicines. 2025 Jun 26;13(7):1563. doi: 10.3390/biomedicines13071563.
10
Severity of the Omicron SARS-CoV-2 variant compared with the previous lineages: A systematic review.奥密克戎（Omicron）SARS-CoV-2 变异株与既往谱系相比的严重程度：一项系统评价。
J Cell Mol Med. 2023 Jun;27(11):1443-1464. doi: 10.1111/jcmm.17747. Epub 2023 May 18.

引用本文的文献

1
Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-omicron or omicron variants: a modelling analysis of the randomized DisCoVeRy trial-authors' response.恩适得对感染前奥密克戎或奥密克戎变异株的COVID-19住院患者的抗病毒作用：随机发现试验的建模分析——作者回应
J Antimicrob Chemother. 2025 Mar 3;80(3):892-893. doi: 10.1093/jac/dkae447.

本文引用的文献

1
Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial.Evusheld 对感染前奥密克戎或奥密克戎变异株的 COVID-19 住院患者的抗病毒效果：一项随机 DisCoVeRy 试验的建模分析。
J Antimicrob Chemother. 2024 Nov 4;79(11):2887-2895. doi: 10.1093/jac/dkae301.
2
A review of mechanistic learning in mathematical oncology.机制学习在数学肿瘤学中的研究综述。
Front Immunol. 2024 Mar 12;15:1363144. doi: 10.3389/fimmu.2024.1363144. eCollection 2024.
3
The lost art of mathematical modelling.数学建模的失落艺术。
Math Biosci. 2023 Aug;362:109033. doi: 10.1016/j.mbs.2023.109033. Epub 2023 May 29.
4
Comparative analysis of within-host diversity among vaccinated COVID-19 patients infected with different SARS-CoV-2 variants.接种疫苗的COVID-19患者中感染不同SARS-CoV-2变体的宿主内多样性比较分析。
iScience. 2022 Nov 18;25(11):105438. doi: 10.1016/j.isci.2022.105438. Epub 2022 Oct 25.
5
SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients.免疫功能低下患者中SARS-CoV-2的进化与免疫逃逸
N Engl J Med. 2022 Jun 23;386(25):2436-2438. doi: 10.1056/NEJMc2202861. Epub 2022 Jun 8.
6
Case report study of the first five COVID-19 patients treated with remdesivir in France.法国首例 5 例 COVID-19 患者接受瑞德西韦治疗的病例研究
Int J Infect Dis. 2020 Sep;98:290-293. doi: 10.1016/j.ijid.2020.06.093. Epub 2020 Jun 30.
7
Mechanistic models versus machine learning, a fight worth fighting for the biological community?机制模型与机器学习，生物学界值得为之奋斗的一场较量？
Biol Lett. 2018 May;14(5). doi: 10.1098/rsbl.2017.0660.
8
Vaccine-induced enhancement of viral infections.疫苗诱导的病毒感染增强。
Vaccine. 2009 Jan 22;27(4):505-12. doi: 10.1016/j.vaccine.2008.10.087. Epub 2008 Nov 18.